Frankfurt, Germany

Thomas Klabunde

This inventor holds 31 USPTO granted patents and 8 published patent applications and 16 EPO patents. Top assignees: Sanofi-A Ventis Deutschland Gmbh, Sanofi, Sanofi-Aventis. Active years: 2003-2014.

USPTO Granted Patents = 31 

% Patents Active = 38.7

 

Average Co-Inventor Count = 7.7

ph-index = 6

Forward Citations = 114(Granted Patents)


Location History:

  • Kelkheim, DE (2010)
  • Frankfurt-am-Main, DE (2003 - 2014)

Company Filing History:


Years Active: 2003-2014

Loading Chart...
Loading Chart...
Areas of Expertise:
Spirocyclic Derivatives
Pyrrolidinone Modulators
Phenylamino-Benzoxazole
Pyranone Acid Derivatives
Methoxyphenyl Derivatives
Phenyloxamides
Acylureas
Hexahydropyrazino Derivatives
Carboxylic Acid Derivatives
Quinoline Derivatives
Benzoylurea Derivatives
Acylphenylurea
31 patents (USPTO):Explore Patents

Title: Inventor Thomas Klabunde - Revolutionizing Technology in Frankfurt-am-Main

Introduction: Thomas Klabunde is a visionary inventor based in Frankfurt-am-Main, Germany, known for his groundbreaking contributions to the field of technology.

Latest Patents: Thomas Klabunde holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Thomas Klabunde has worked with leading research institutions and tech companies, consistently pushing the boundaries of technological advancement.

Collaborations: Throughout his career, Thomas Klabunde has collaborated with top scientists, engineers, and researchers globally, fostering a culture of innovation and knowledge exchange.

Conclusion: Thomas Klabunde's relentless pursuit of innovation and his passion for creating technology that makes a difference continue to inspire the next generation of inventors and entrepreneurs worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…